Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective

10.1016/j.jtcme.2020.05.004

Suraphan Panyod；Chi-Tang Ho；Lee-Yan Sheen

COVID-19 ； SARS-CoV-2 ； Coronavirus ； Dietary therapy ； Herbal medicine ； Herbs ； Prevention

Journal of Traditional and Complementary Medicine

10卷4期（2020 / 07 / 01）

420 - 427

英文

A novel coronavirus disease (COVID-19), transmitted from humans to humans, has rapidly become the pandemic responsible for the current global health crisis. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is said to be of zoonotic origin. This review describes the etiology and signs and symptoms as well as the current allopathic therapy for COVID-19. Additionally, findings of previous studies on the immunomodulatory effects and antiviral activities of particular foods and herbs on influenza virus and coronaviruses have been collated, with the aim of promoting the use of dietary therapy and herbal medicine as COVID-19 preventive therapies, while specific drugs and vaccines are yet to be discovered or are still under development. The volume of existing reports is irrefutable evidence that foods and herbs possess a potential antiviral ability against SARS-CoV-2 and can prevent COVID-19. Foods and herbs could be used as dietary or complementary therapy to prevent infection and strengthen immunity, as antiviral agents for masks, as disinfectants to curb aerosol transmission, or as sanitizing agents to disinfect surfaces. However, these hypotheses need to be experimentally verified for SARS-CoV-2 and COVID-19 patients.

1. Wen, CC,Shyur, LF,Jan, JT(2011).Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication.J Tradit Complement Med,1(1),41-50.
   連結：
2. Bedford, J,Enria, D,Giesecke, J(2020).For the WHO strategic and technical advisory group for infectious hazards. COVID-19: towards controlling of a pandemic.Lancet,395(10229),1015-1018.
3. CDC. Information for clinicians on investigational therapeutics for patients with COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html; 2020.
4. Chen, CJ,Michaelis, M,Hsu, HK(2008).Toona sinensis roem tender leaf extract inhibits SARS coronavirus replication.J Ethnopharmacol,120(1),108-111.
5. Chen, MY,Li, H,Lu, XX(2019).Houttuynia cordata polysaccharide alleviated intestinal injury and modulated intestinal microbiota in h1n1 virus infected.Chin J Nat Med,17(3),187-197.
6. Chen, N,Zhou, M,Dong, X(2020).Epidemiological and clinical characteristics of 99 cases of 2019 Novel Coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet,395(10223),507-513.
7. Cooke, B,Ernst, E(2000).Aromatherapy: a systematic review.Br J Gen Pract,50(455),493-496.
8. Di Gennaro, F,Pizzol, D,Marotta, C(2020).Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review.Int J Environ Res Publ Health,17(8)
9. Ding, YW,Zeng, LJ,Li, RF(2017).The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function.Bmc Complem Altern M.,17(1),130.
10. Forster, P,Forster, L,Renfrew, C,Forster, M(2020).Phylogenetic network analysis of SARS-CoV-2 genomes.Proc Natl Acad Sci USA.,117(17),9241-9243.
11. Gautret, P,Lagier, J-C,Parola, P(2020).Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.Int J Antimicrob Agents,56(1),105949.
12. Grant, WB,Lahore, H,McDonnell, SL(2020).Evidence that vitamin d supplementation could reduce risk of influenza and COVID-19 infections and deaths.Nutrients,12(4),988.
13. Greenhalgh, T,Schmid, MB,Czypionka, T,Bassler, D,Gruer, L(2020).Face masks for the public during the COVID-19 crisis.BMJ,369,m1435.
14. Grein, J,Ohmagari, N,Shin, D(2020).Compassionate use of remdesivir for patients with severe COVID-19.NEJM,382,2327-2336.
15. He, YQ,Cai, L,Qian, QG(2020).Anti-influenza a (H1N1) viral and cytotoxic sesquiterpenes from carpesium abrotanoides.Phytochem Lett,35,41-45.
16. Hoever, G,Baltina, L,Michaelis, M(2005).Antiviral activity of glycyrrhizic acid derivatives against sars-coronavirus.J Med Chem,48(4),1256-1259.
17. Hoffmann, M,Kleine-Weber, H,Schroeder, S(2020).SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.Cell,181(2),271-280.
18. Huang, C,Wang, Y,Li, X(2020).Clinical features of patients infected with 2019 novel coronavirus in wuhan, China.Lancet,395(10223),497-506.
19. Huang, J,Su, D,Feng, Y,Liu, K,Song, Y(2014).Antiviral herbs-present and future.Infect Disord - Drug Targets,14(1),61-73.
20. Kim, M,Nguyen, DV,Heo, Y,Park, KH,Paik, HD,Kim, YB(2020).Antiviral activity of fritillaria thunbergii extract against human influenza virus H1N1 (PR8) in vitro, in ovo and in vivo.Microbiol Biotechnol,30(2),172-177.
21. Lam, TT,Shum, MH,Zhu, HC(2020).Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins.Nature
22. Leung, CC,Lam, TH,Cheng, KK(2020).Mass masking in the COVID-19 epidemic: people need guidance.Lancet,395(10228),945.
23. Li, SY,Chen, C,Zhang, HQ(2005).Identification of natural compounds with antiviral activities against sars-associated coronavirus.Antivir Res,67(1),18-23.
24. Li, YH,Lai, CY,Su, MC,Cheng, JC,Chang, YS(2019).Antiviral activity of Portulaca oleracea L. against influenza a viruses.J Ethnopharmacol,241
25. Ling, LJ,Lu, Y,Zhang, YY(2020).Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and toll-like receptor signalling.Phytomedicine,67,153150.
26. Liu, P,Jiang, JZ,Wan, XF(2020).Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?.PLoS Pathog,16(5),e1008421.
27. Liu, Y,Ning, Z,Chen, Y(2020).Aerodynamic characteristics and rna concentration of SARS-CoV-2 aerosol in wuhan hospitals during COVID-19 outbreak.Nature,582,557-560.
28. Lu, R,Zhao, X,Li, J(2020).Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet,395(10224),565-574.
29. Luo, H,Tang, QL,Shang, YX(2020).Can Chinese medicine be used for prevention of Corona Virus Disease 2019 (COVID-19)? a review of historical classics, research evidence and current prevention programs.Chin J Integr Med.,26(4),243-250.
30. Mehrbod, P,Amini, E,Tavassoti-Kheiri, M(2009).Antiviral activity of garlic extract on influenza virus.Iran J Virol,3(1),19-23.
31. Menni, C,Valdes, A,Freydin, MB(2020).Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection.Nature Medicine
32. Pyankov, OV,Usachev, EV,Pyankova, O,Agranovski, IE(2012).Inactivation of airborne influenza virus by tea tree and eucalyptus oils.Aerosol Sci Tech,46(12),1295-1302.
33. Quan, FS,Compans, RW,Cho, YK,Kang, SM(2007).Ginseng and salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.Vaccine,25(2),272-282.
34. Rasool, A,Khan, MU,Ali, MA(2017).Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (ginger) and allium sativum (garlic) in chick embryos.Pak J Pharm Sci.,30(4),1341-1344.
35. Runfeng, L,Yunlong, H,Jicheng, H(2020).Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).Pharmacol Res,156,104761.
36. Sadlon, AE,Lamson, DW(2010).Immune-modifying and antimicrobial effects of eucalyptus oil and simple inhalation devices.Alternative Med Rev,15(1),33-42.
37. Sanders, JM,Monogue, ML,Jodlowski, TZ,Cutrell, JB(2020).Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review.J Am Med Assoc.,323(18),1824-1836.
38. Saul, AW(2020).Nutritional treatment of coronavirus.Orthomol Med News Ser,16(6)
39. Serafino, A,Vallebona, PS,Andreola, F(2008).Stimulatory effect of eucalyptus essential oil on innate cell-mediated immune response.BMC Immunol,9,17.
40. Su, H,Yao, S,Zhao, W(2020).,未出版
41. Swamy, MK,Akhtar, MS,Sinniah, UR(2016).Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review.Evid-Based Compl Alt Med,2016,3012462.
42. Tan, BKH,Vanitha, J(2004).Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review.Curr Med Chem,11(11),1423-1430.
43. Usachev, EV,Pyankov, OV,Usacheva, OV,Agranovski, IE(2013).Antiviral activity of tea tree and eucalyptus oil aerosol and vapour.J Aerosol Sci.,59,22-30.
44. Vimalanathan, S,Hudson, J(2014).Anti-influenza virus activity of essential oils and vapors.Amer J Essential Oil Nat Prod,2(1),47-53.
45. Wang, C,Horby, PW,Hayden, FG,Gao, GF(2020).A novel coronavirus outbreak of global health concern.Lancet,395(10223),470-473.
46. WHO(2020).WHO. Laboratory Biosafety Guidance Related to the Novel Coronavirus (2019- nCOV). 2020..
47. WHO. Coronavirus disease (covid-19) pandemic. 17. 2020:2690, 8 https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=cj0kcqjwzzj2brdvarisabs3l9l2f-qlqqz-ni5zltz8ytn8uvinukfefr_jrf3l1bastxo8zlddogyaai9realw_wcb
48. Wu, F,Zhao, S,Yu, B(2020).A new coronavirus associated with human respiratory disease in China.Nature,579(7798),265-269.
49. Wu, SH,Patel, KB,Booth, LJ,Metcalf, JP,Lin, HK,Wu, WX(2010).Protective essential oil attenuates influenza virus infection: an in vitro study in mdck cells.BMC Compl Alternative Med,10,69.
50. Yang, Y,Islam, MS,Wang, J,Li, Y,Chen, X(2020).Traditional Chinese medicine in the treatment of patients infected with 2019-New Coronavirus (SARS-CoV-2): a review and perspective.Int J Biol Sci.,16(10),1708-1717.
51. You, HL,Huang, CC,Chen, CJ,Chang, CC,Liao, PL,Huang, ST(2018).Anti-pandemic influenza a (H1N1) virus potential of catechin and gallic acid.J Chin Med Assoc,81(5),458-468.
52. Zhang, T,Wu, Q,Zhang, Z(2020).Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak.Curr Biol,30(7),1346-1351.
53. Zhang, YS,Yao, J,Qi, X,Liu, X,Lu, XQ,Feng, GZ(2017).Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo.Antivir Ther,22(7),599-611.

1. Lee-Yan Sheen,Ciro Isidoro,Ashley Chiung-Fang Chang(2022).Natural products as a source of novel drugs for treating SARS-CoV2 infection.Journal of Traditional and Complementary Medicine,12(1),1-5.
2. Suban K. Sahoo,Seshu Vardhan(2022).Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations.Journal of Traditional and Complementary Medicine,12(1),44-54.
3. Tewin Tencomnao,Siriporn Chuchawankul,Panthakarn Rangsinth,Chanin Sillapachaiyaporn,Atsadang Theerasri,Anchalee Prasansuklab(2021).Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.Journal of Traditional and Complementary Medicine,11(2),144-157.
4. Vijay Kumar Bhardwaj,Sanjay Kumar,Rituraj Purohit,Rahul Singh,Jatin Sharma(2022).In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors.Journal of Traditional and Complementary Medicine,12(1),35-43.
5. Yi-Wei Zhu,Xu-Dong Hu,Xiao-Ling Wang,Xiao-Feng Yan,Ting-Jie Ye,Jing Hu,Feng-Jun Qiu,Cheng-Hai Liu(2021).Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods.Journal of Traditional and Complementary Medicine,11(2),180-187.